|
|||||
|
|
A phase II study of risk-adapted intravenous melphalan in patients with AL amyloidosis |
|
| Authors: | Mollee Peter Tiley Campbell Cunningham Ilona Moore John Prince H Miles Cannell Paul Gibbons Steve Tate Jill Paul Sanjoy Mar Fan Helen Gill Devinder S |
| Affiliation: | UCSF Global Health Sciences, 950 Mee Lane, St Helena, CA 94574, USA. zieglerj@globalhealth.ucsf.edu |
| Abstract: | |
| Keywords: | AL amyloidosis intravenous melphalan autologous stem cell transplantation brain natriuretic peptide toxicity |
| 本文献已被 PubMed 等数据库收录！ | |